These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2886036)

  • 1. The 1980s: a patient-specific therapeutic approach in hypertension.
    DeQuattro V
    Am Heart J; 1987 Jul; 114(1 Pt 2):224-6. PubMed ID: 2886036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient profiling: individualization of hypertension therapy.
    Taylor RB
    Am Fam Physician; 1990 Nov; 42(5 Suppl):29S-31S, 34S-36S. PubMed ID: 1978541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists in elderly and black hypertensive patients. Therapeutic controversies.
    Zing W; Ferguson RK; Vlasses PH
    Arch Intern Med; 1991 Nov; 151(11):2154-62. PubMed ID: 1683219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rational hypertension treatment].
    Canova CR
    Schweiz Med Wochenschr; 1996 Aug; 126(33):1394-9. PubMed ID: 8830397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.
    Brewster LM; Seedat YK
    BMC Med; 2013 May; 11():141. PubMed ID: 23721258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update in pharmacologic treatment of hypertension.
    Ferdinand KC
    Cardiol Clin; 2001 May; 19(2):279-94, v. PubMed ID: 11407110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to treat hypertension in blacks: review of the evidence.
    Kola LD; Sumaili EK; Krzesinski JM
    Acta Clin Belg; 2009; 64(6):466-76. PubMed ID: 20101869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent trend in the research of hypertension in Japan. Choice of antihypertensive agents in hemodynamic aspects to match pathophysiology and pharmacology in essential hypertension].
    Tsukiyama H; Otsuka K
    Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1811-5. PubMed ID: 2907995
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy.
    Dieguez-Lucena JL; Aranda-Lara P; Ruiz-Galdón M; García-Villanova J; Morell-Ocaña M; Reyes-Engel A
    Hypertension; 1996 Jul; 28(1):98-103. PubMed ID: 8675271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life and antihypertensive therapy].
    Vajó Z; Székács B
    Orv Hetil; 1993 Nov; 134(45):2477-9. PubMed ID: 7902554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension-related morbidity and mortality in African Americans--why we need to do better.
    Ferdinand KC; Saunders E
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1 Suppl 1):21-30. PubMed ID: 16415637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose combination therapy in hypertension: pros.
    Taddei S
    High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):55-7. PubMed ID: 22867090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.